Management of bleeding with uremia and liver disease

    Research output: Contribution to journalReview articlepeer-review

    11 Scopus citations


    Bleeding can complicate the clinical course of both liver disease and uremia. The pathogenesis of bleeding in both syndromes is complex. A variety of options are available for treatment of uremic bleeding including desmopressin, erythropoietin, and estrogens. Bleeding complications of liver disease reflect the importance of this organ for the production of both coagulation factors and thrombopoietin. Careful assessment of both the patient's clinical situation and laboratory findings is important for tailoring therapy of the bleeding patient. (C) 1999 Lippincott Williams and Wilkins, Inc.

    Original languageEnglish (US)
    Pages (from-to)329-333
    Number of pages5
    JournalCurrent opinion in hematology
    Issue number5
    StatePublished - Dec 1 1999

    ASJC Scopus subject areas

    • Hematology


    Dive into the research topics of 'Management of bleeding with uremia and liver disease'. Together they form a unique fingerprint.

    Cite this